{"id":18229,"date":"2026-04-01T13:39:07","date_gmt":"2026-04-01T13:39:07","guid":{"rendered":"https:\/\/www.colorectalcancercanada.com\/?post_type=drug&#038;p=18229"},"modified":"2026-04-08T16:09:33","modified_gmt":"2026-04-08T16:09:33","slug":"oxaliplatin","status":"publish","type":"drug","link":"https:\/\/www.colorectalcancercanada.com\/fr\/drug\/oxaliplatin\/","title":{"rendered":"Oxaliplatin"},"content":{"rendered":"<p><strong>Indication :<\/strong><\/p>\n<p>Pour le traitement du cancer colorectal, tant en adjuvant qu&rsquo;en cas de m\u00e9tastases. Il est couramment utilis\u00e9 en association avec le 5-fluorouracile et la leucovorine (FOLFOX) ou la cap\u00e9citabine (CAPOX\/XELOX) pour le traitement du cancer du c\u00f4lon de stade III apr\u00e8s r\u00e9section chirurgicale et pour le cancer colorectal m\u00e9tastatique (mCRC) en tant que traitement de premi\u00e8re intention ou de deuxi\u00e8me intention. L&rsquo;oxaliplatine est \u00e9galement incluse dans le protocole FOLFOXIRI pour certains patients atteints d&rsquo;une maladie avanc\u00e9e.<\/p>\n","protected":false},"template":"","crc_subtype":[401],"drug_stage":[417,402],"therapy_line":[418],"health_canada_approval":[404],"cda_review":[],"cda_recommendation":[],"inesss_review":[],"inesss_recommendation":[],"pcpa_status":[],"public_reimbursement":[411,410,454,450,451,414,457,453,413,412,452,456,455],"class_list":["post-18229","drug","type-drug","status-publish","hentry","crc_subtype-none-fr","drug_stage-iii-fr","drug_stage-iv-fr","therapy_line-premiere-ligne","health_canada_approval-approved-fr","public_reimbursement-alberta-fr","public_reimbursement-colombie-britannique-fr","public_reimbursement-i-p-e","public_reimbursement-manitoba-fr","public_reimbursement-n-b","public_reimbursement-ns-fr","public_reimbursement-nt","public_reimbursement-on","public_reimbursement-qc-fr","public_reimbursement-sk-fr","public_reimbursement-t-n-l","public_reimbursement-t-n-o","public_reimbursement-yn"],"_links":{"self":[{"href":"https:\/\/www.colorectalcancercanada.com\/fr\/wp-json\/wp\/v2\/drug\/18229","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.colorectalcancercanada.com\/fr\/wp-json\/wp\/v2\/drug"}],"about":[{"href":"https:\/\/www.colorectalcancercanada.com\/fr\/wp-json\/wp\/v2\/types\/drug"}],"wp:attachment":[{"href":"https:\/\/www.colorectalcancercanada.com\/fr\/wp-json\/wp\/v2\/media?parent=18229"}],"wp:term":[{"taxonomy":"crc_subtype","embeddable":true,"href":"https:\/\/www.colorectalcancercanada.com\/fr\/wp-json\/wp\/v2\/crc_subtype?post=18229"},{"taxonomy":"drug_stage","embeddable":true,"href":"https:\/\/www.colorectalcancercanada.com\/fr\/wp-json\/wp\/v2\/drug_stage?post=18229"},{"taxonomy":"therapy_line","embeddable":true,"href":"https:\/\/www.colorectalcancercanada.com\/fr\/wp-json\/wp\/v2\/therapy_line?post=18229"},{"taxonomy":"health_canada_approval","embeddable":true,"href":"https:\/\/www.colorectalcancercanada.com\/fr\/wp-json\/wp\/v2\/health_canada_approval?post=18229"},{"taxonomy":"cda_review","embeddable":true,"href":"https:\/\/www.colorectalcancercanada.com\/fr\/wp-json\/wp\/v2\/cda_review?post=18229"},{"taxonomy":"cda_recommendation","embeddable":true,"href":"https:\/\/www.colorectalcancercanada.com\/fr\/wp-json\/wp\/v2\/cda_recommendation?post=18229"},{"taxonomy":"inesss_review","embeddable":true,"href":"https:\/\/www.colorectalcancercanada.com\/fr\/wp-json\/wp\/v2\/inesss_review?post=18229"},{"taxonomy":"inesss_recommendation","embeddable":true,"href":"https:\/\/www.colorectalcancercanada.com\/fr\/wp-json\/wp\/v2\/inesss_recommendation?post=18229"},{"taxonomy":"pcpa_status","embeddable":true,"href":"https:\/\/www.colorectalcancercanada.com\/fr\/wp-json\/wp\/v2\/pcpa_status?post=18229"},{"taxonomy":"public_reimbursement","embeddable":true,"href":"https:\/\/www.colorectalcancercanada.com\/fr\/wp-json\/wp\/v2\/public_reimbursement?post=18229"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}